Colleen Hoke, Don Lazas are fresh off Frist-backed Series A, now at 12 centers and running.
A rigorous study of TN lifesciences is afoot and advocates are clearly positioning to push for public and private support.
The word is just getting out about new entrant in Tennessee biopharm ecosystem.
Transplanted entrepreneur mulls capital and advisors, preps for full market entry
Entrepreneur who also leads mentor network says his new firm is operational.
[updated] Opioid abuse crisis is latest driver in startup business opportunity.
[updated] Health:Further, Ingram, Case, McWhorter, DART Music and DATAFlyte raises, SeedHatchlings and more.
[updated] Treading carefully to 'get program right', industry aims for step-by-step progress.
Updates on investors, startups and ideas with ties to our region.
Breast cancer target, regulatory progress and further capital raise action likely.
[Updated] Nashville VC continues building its healthcare portfolio.
Seed to B-round scenario begins to emerge, with pharmacogenetic testing a driver.
[updated] Financing spurs Type 2 diabetes, non-alcoholic fatty liver programs
[updated] With sector veterans on its board and access to capital, this startup girds for raise.
A change at the helm of one of Tennessee's most recognized institutions.
Carmichael's long-standing network won him an early taste of cross-border startup
[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders
Medical devices may get a boost from the collaboration of two life-science weighted funds and an innovation driver
Law firm broadens its already sizeable footprint, plants flag in dealing with early-stage ventures
Vanderbilt pharma program inches cautiously toward tech transfer, while key faculty member keeps firm hand on the tiller
The yet-to-be-operational TNInvestco capital-formation program seems to have kindled fresh interest in key sectors
From his Nashville vantage-point, Jason Dinger works to find opportunities that produce a plus for the community's healthcare
TTDC lands prominent healthcare CEO, scientist and policy influential to help navigate the shores of business, academe and government
At deal-making summit, investment bankers and others say focus on regulatory pressure for cost-reductions, rather than on next President
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: